ConforMIS Announces $10 Million Senior Debt Financing with Merrill Lynch Capital

    LEXINGTON, Mass., Aug. 6 /PRNewswire/ -- ConforMIS, an innovative
 medical device company dedicated to developing and marketing
 patient-specific orthopedic implants, today announced the completion of a
 $10 million senior debt facility with Merrill Lynch Capital, a division of
 Merrill Lynch Business Financial Services.
     The $10 million debt facility will be used to support the growth of the
 business in preparation for a mezzanine round of financing. Proceeds from
 the debt facility will be used to expand the commercialization
 infrastructure, including expansion of the product design and manufacturing
 capabilities as well as the sales force.
     "This credit facility will provide ConforMIS with increased financial
 flexibility to accelerate the commercialization of our family of
 patient-specific knee implants, while at the same time permitting the
 continued development of our expanding R&D product pipeline," said Patrick
 Hess, CEO of ConforMIS.
     Philipp Lang, Chairman of the Board of ConforMIS, said: "We believe
 this facility is an attractive way to finance the Company's growth at an
 attractive cost of capital and with minimal dilution to our existing
 shareholders."
     About ConforMIS, Inc.
     ConforMIS is a privately held medical device company whose mission is
 to provide best-in-class, minimally invasive implants for orthopedics and
 sports medicine through the use of its proprietary iFit Technology(tm). The
 iFit Technology is a patent-protected, software-enabled process for
 converting CT and MR imaging data into personalized, patient-specific
 implants. This 'image-to-implant' technology allows for precisely sized and
 shaped implants that reduce or eliminate the need for cartilage or bone
 resection and radically simplify the surgical procedure.
     With over 100 allowed and pending patent applications, ConforMIS has
 developed a portfolio of diverse, integrated intellectual property spanning
 multiple aspects of orthopedics. To date, the company has developed a
 comprehensive line of minimally invasive bone and cartilage preserving knee
 implants for all stages of osteoarthritis. For more information please
 visit http://www.conformis.com.
     About Merrill Lynch Capital
     Merrill Lynch Capital, a division of Merrill Lynch Business Financial
 Services Inc., is a leading commercial finance business providing a broad
 range of structured financing solutions to middle market companies
 nationwide. The Healthcare Finance Group of Merrill Lynch Capital provides
 senior financing solutions for middle market healthcare companies, offering
 cash flow, asset, life sciences related and real estate based credit
 facilities and junior secured debt, and equity co-investments. Merrill
 Lynch Capital is an affiliate of Merrill Lynch Bank USA. For more
 information, please visit http://www.mlcapital.ml.com.
     Contacts:
 
     Patrick Hess, CEO
     650-286-4151 ext. 1102
 
     Jong Lee, SVP Marketing
     781-860-5111 ext. 1107
     This release was issued through eReleases(TM). For more information,
 visit http://www.ereleases.com.
 
 

SOURCE ConforMIS, Inc.